| 14.89 -0.07 (-0.47%) | 12-15 15:59 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 17.72 | 1-year : | 20.7 |
| Resists | First : | 15.17 | Second : | 17.72 |
| Pivot price | 14.57  |
|||
| Supports | First : | 13.84 | Second : | 13.02 |
| MAs | MA(5) : | 14.94 |
MA(20) : | 14.29 |
| MA(100) : | 14.6 |
MA(250) : | 0 | |
| MACD | MACD : | 0.2 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 84.9 |
D(3) : | 89 |
| RSI | RSI(14): 60.5 |
|||
| 52-week | High : | 20.19 | Low : | 13.02 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CCAP ] has closed below upper band by 26.9%. Bollinger Bands are 1.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 15.17 - 15.25 | 15.25 - 15.31 |
| Low: | 14.65 - 14.73 | 14.73 - 14.8 |
| Close: | 14.77 - 14.9 | 14.9 - 15 |
Crescent Capital BDC, Inc. is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Wed, 10 Dec 2025
Crescent Capital BDC (NASDAQ:CCAP) Rating Increased to Hold at Zacks Research - MarketBeat
Sat, 06 Dec 2025
Crescent Capital BDC, Inc. (NASDAQ:CCAP) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Fri, 28 Nov 2025
Crescent Capital BDC: Attractive BDC, But More Downside Could Be Likely (CCAP) - Seeking Alpha
Wed, 19 Nov 2025
Crescent Capital BDC: 13% Yield And 31% Discount Make It A Buy (NASDAQ:CCAP) - Seeking Alpha
Tue, 18 Nov 2025
Insider Buying: Gerhard Lombard Acquires Shares in Crescent Capi - GuruFocus
Thu, 13 Nov 2025
Crescent Capital BDC Q3 2025 presentation: NAV declines amid stable income - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 37 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 3.2 (%) |
| Held by Institutions | 68.2 (%) |
| Shares Short | 254 (K) |
| Shares Short P.Month | 265 (K) |
| EPS | 0.97 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 19.28 |
| Profit Margin | 20.8 % |
| Operating Margin | 75.1 % |
| Return on Assets (ttm) | 5 % |
| Return on Equity (ttm) | 4.9 % |
| Qtrly Rev. Growth | -19.9 % |
| Gross Profit (p.s.) | 4.67 |
| Sales Per Share | 4.67 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -53.5 % |
| Operating Cash Flow | 49 (M) |
| Levered Free Cash Flow | 40 (M) |
| PE Ratio | 15.35 |
| PEG Ratio | 0 |
| Price to Book value | 0.77 |
| Price to Sales | 3.18 |
| Price to Cash Flow | 11.19 |
| Dividend | 0.41 |
| Forward Dividend | 0 |
| Dividend Yield | 2.8% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|